logo

For the Inventor, By the Inventor

Schenectady, NY, United States of America

Kira McGinty

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 7.3

ph-index = 4

Forward Citations = 79(Granted Patents)


Location History:

  • Medford, MA (US) (2010 - 2011)
  • Schenectady, NY (US) (2011 - 2013)
  • Schenctady, NY (US) (2013)

Company Filing History:

goldMedal8 out of 1,151 
 
Vertex Pharmaceuticals, Inc.
 patents

Years Active: 2010-2013

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 8518938 - c-MET protein kinase inhibitors (2013-08-27),
2. 8481538 - Heterocyclic inhibitors of c-Met and uses thereof (2013-07-09),
3. 8481524 - c-MET protein kinase inhibitors (2013-07-09),
4. 8269012 - Aminopyrazole triazolothiadiazole inhibitors of c-met protein kinase (2012-09-18),
5. 8232406 - c-MET protein kinase inhibitors (2012-07-31),
6. 7998987 - Inhibitors of c-Met and uses thereof (2011-08-16),
7. 7872031 - c-MET protein kinase inhibitors (2011-01-18),
8. 7728017 - Inhibitors of c-Met and uses thereof (2010-06-01),

Title: The Innovative Mind of Kira McGinty

Introduction: Kira McGinty, a pioneering inventor hailing from Schenectady, NY, is known for her groundbreaking contributions to the field of technology.

Latest Patents: Kira McGinty holds several patents in the realm of artificial intelligence and renewable energy technologies, showcasing her commitment to creating a sustainable future.

Career Highlights: With a career spanning over two decades, Kira McGinty has worked with top research institutions and leading tech companies to develop cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout her career, Kira McGinty has collaborated with renowned scientists, engineers, and inventors, pooling their expertise to push the boundaries of innovation further.

Conclusion: Kira McGinty's passion for innovation and her relentless pursuit of excellence continue to inspire the next generation of inventors and shape the technological landscape for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…